Home  /  Western and Central Africa  /  GMB

Gambia

The Gambia appears only through international and donor bodies that compile figures across many countries, and no figures for the country are read directly from a national publisher. The assessment of national sources, country by country, is set out on the Methods page.

24,000
People living with HIV, 2025
WHO Global Health Observatory
52.0%
On antiretroviral treatment, 2025
WHO Global Health Observatory
$957k
United States HIV disbursements, 2026
ForeignAssistance.gov
$7.9m
External HIV financing, all donors, 2024
OECD Creditor Reporting System
External HIV financing
OECD CRS · ForeignAssistance.gov
$0$5m$10m200220052008201120142017202020232026$7.9m$100k$7.9m$957k
  • All donors
  • United States, OECD record
  • The Global Fund
  • United States, self-reported
YearAll donorsUnited States, OECD recordThe Global FundUnited States, self-reported
2002 $761k — — —
2003 $1.7m — — —
2004 $5.1m — $1.3m —
2005 $7.6m $40k $3.9m $29k
2006 $3.3m $29k $2.2m $40k
2007 $3.1m $163k $2.7m $85k
2008 $3.2m $60k $2.6m $128k
2009 $6.2m $45k $6.0m $41k
2010 $6.5m $77k $6.0m $68k
2011 $6.7m $165k $6.1m $114k
2012 $5.2m $216k $4.8m $300k
2013 $10.6m $121k $9.5m $115k
2014 $6.9m $148k $3.7m $122k
2015 $4.2m — $3.6m $35k
2016 $4.0m $195k $3.7m $213k
2017 $4.6m $167k $4.3m $201k
2018 $1.4m $222k $1.1m $222k
2019 $396k $331k — $231k
2020 $5.1m $105k $4.5m $202k
2021 $6.6m — $6.6m $146k
2022 $7.0m — $6.9m $226k
2023 $9.5m $100k $9.4m $500k
2024 $7.9m — $7.9m $435k
2025 — — — $410k
2026 — — — $957k

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Disbursements reported for the country. The OECD record and the United States self-reported record are drawn separately. The two records cover the same United States disbursements, but the OECD record is filed by calendar year and the self-reported record by United States fiscal year.

People living with HIV and people on treatment
UNAIDS AIDSinfo
010k20k30k20002003200620092012201520182021202425,00011,000
  • People living with HIV
  • People on treatment
YearPeople living with HIVPeople living with HIV (lower)People living with HIV (upper)People on treatment
2000 13,000 9,300 17,000 —
2001 14,000 11,000 19,000 —
2002 16,000 12,000 21,000 —
2003 17,000 13,000 23,000 —
2004 18,000 14,000 24,000 —
2005 19,000 15,000 26,000 —
2006 20,000 16,000 27,000 —
2007 21,000 17,000 28,000 —
2008 22,000 17,000 29,000 —
2009 23,000 18,000 30,000 —
2010 23,000 19,000 30,000 2,000
2011 24,000 19,000 31,000 3,100
2012 25,000 20,000 32,000 3,800
2013 25,000 21,000 33,000 4,000
2014 26,000 21,000 33,000 4,400
2015 26,000 21,000 33,000 5,000
2016 26,000 21,000 33,000 6,100
2017 26,000 21,000 34,000 6,800
2018 26,000 21,000 34,000 7,500
2019 26,000 21,000 33,000 8,200
2020 26,000 21,000 33,000 8,300
2021 26,000 20,000 33,000 8,700
2022 26,000 20,000 32,000 9,600
2023 25,000 20,000 32,000 10,000
2024 25,000 20,000 32,000 11,000

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Modelled estimates. The shaded area is the published uncertainty interval around the number of people living with HIV, because a single estimate without the interval would overstate the precision of the model.

The treatment cascade
UNAIDS AIDSinfo
0%20%40%60%2010201220142016201820202022202464.0%44.0%
  • Diagnosed
  • On treatment
YearDiagnosedOn treatment
2010 26.0% 9.0%
2011 30.0% 13.0%
2012 34.0% 16.0%
2013 37.0% 16.0%
2014 41.0% 17.0%
2015 44.0% 19.0%
2016 47.0% 23.0%
2017 49.0% 26.0%
2018 51.0% 29.0%
2019 54.0% 31.0%
2020 55.0% 32.0%
2021 57.0% 33.0%
2022 59.0% 38.0%
2023 61.0% 40.0%
2024 64.0% 44.0%

15 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Every line is a percentage of all people living with HIV, so the three lines share a denominator and can be compared directly. Viral suppression in the figure is the share of all people living with HIV who are virally suppressed, and not the narrower third 95 target, which counts only people on treatment.

Sources of the figures for Gambia

3,131 rows

SourceTypeRowsIndicators YearsRead fromRetrieved
UNICEF HIV/AIDS dataset Modelled estimate 1,376 5 2010–2025 sdmx.data.unicef.org 2026-10-20
UNAIDS AIDSinfo Modelled estimate 771 26 2000–2024 aidsinfo.unaids.org 2026-10-20
WHO Global Health Observatory Modelled estimate 247 12 2000–2025 ghoapi.azureedge.net 2026-10-12
UNAIDS HIV sub-national estimates viewer (Naomi) Modelled estimate 126 7 2025 nmviewerserver.azurewebsites.net 2026-10-14
Demographic and Health Surveys Survey 121 4 2013–2019 api.dhsprogram.com 2026-10-16
WHO Global Tuberculosis Programme Programme record 111 16 2000–2024 extranet.who.int 2026-10-16
Global Fund Data Service Programme record 86 11 2017–2025 fetch.theglobalfund.org 2026-10-12
IATI, through d-portal Expenditure account 59 3 2000–2026 d-portal.org 2026-10-12
OECD Creditor Reporting System Expenditure account 59 3 2002–2024 sdmx.oecd.org 2026-10-12
World Bank Open Data Modelled estimate 51 2 2000–2025 api.worldbank.org 2026-10-12
ForeignAssistance.gov Expenditure account 49 4 2005–2026 foreignassistance.gov 2026-10-29
WHO HIV testing services dashboard Programme record 32 4 2018–2024 eic-database-290813.ew.r.appspot.com 2026-10-14
WHO Global Health Expenditure Database Expenditure account 28 7 2018–2021 apps.who.int 2026-10-12
UNAIDS Global AIDS Monitoring expenditure database Expenditure account 10 8 2019–2024 hivfinancial.unaids.org 2026-10-12
Global Fund allocations Expenditure account 4 1 2017–2026 fetch.theglobalfund.org 2026-10-12
UNAIDS Data 2025 country databook Expenditure account 1 1 2019 aidsinfo.unaids.org 2026-10-15

Indicators held

72 of 150

IndicatorDomainUnitRows YearsSourcesMost recent value
Actual expenditure on collaborative TB/HIV activities Financing USD 5 2019–2024 WHO Global Tuberculosis Programme $77k (2024)
Budget required for collaborative TB/HIV activities Financing USD 1 2023 WHO Global Tuberculosis Programme $49k (2023)
Country-reported HIV expenditure, all sources Financing USD 5 2014–2024 UNAIDS AIDSinfo, UNAIDS Global AIDS Monitoring expenditure database $33k (2024)
Domestic funding received by the national TB programme Financing USD 5 2019–2024 WHO Global Tuberculosis Programme $93k (2024)
Domestic public HIV expenditure Financing USD 2 2019 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $1.0m (2019)
Expected Global Fund funding for the national TB programme Financing USD 1 2023 WHO Global Tuberculosis Programme $1.1m (2023)
Expected domestic funding for the national TB programme Financing USD 1 2023 WHO Global Tuberculosis Programme $18k (2023)
Expected funding for collaborative TB/HIV activities Financing USD 1 2023 WHO Global Tuberculosis Programme $49k (2023)
External HIV and STD spending, national health accounts Financing USD 4 2018–2021 WHO Global Health Expenditure Database $3.3m (2021)
External HIV financing (all donors, ODA) Financing USD 23 2002–2024 OECD Creditor Reporting System $7.9m (2024)
External HIV financing from governments other than the United States (IATI) Financing USD 21 2000–2025 IATI, through d-portal $0 (2025)
External HIV financing from multilateral bodies other than the Global Fund (IATI) Financing USD 15 2012–2026 IATI, through d-portal $70k (2026)
External HIV financing from the United States (ODA) Financing USD 38 2005–2026 ForeignAssistance.gov, OECD Creditor Reporting System $957k (2026)
Funding received for collaborative TB/HIV activities Financing USD 5 2019–2024 WHO Global Tuberculosis Programme $77k (2024)
Global Fund HIV allocation for a whole three-year cycle, not an annual figure Financing USD per three-year allocation cycle 4 2017–2026 Global Fund allocations 15,448,649 (2026)
Global Fund HIV disbursements to the country Financing USD 44 2004–2026 IATI, through d-portal, OECD Creditor Reporting System, UNAIDS Global AIDS Monitoring expenditure database $3.4m (2026)
Global Fund funding received by the national TB programme Financing USD 5 2019–2024 WHO Global Tuberculosis Programme $1.4m (2024)
Government HIV and STD spending as a share of government health spending Financing percent 4 2018–2021 WHO Global Health Expenditure Database 6.0% (2021)
Government HIV and STD spending, national health accounts Financing USD 4 2018–2021 WHO Global Health Expenditure Database $1.6m (2021)
HIV and STD spending as a share of all external health spending Financing percent 4 2018–2021 WHO Global Health Expenditure Database 12.2% (2021)
HIV and STD spending as a share of all health spending Financing percent 4 2018–2021 WHO Global Health Expenditure Database 6.9% (2021)
HIV and STD spending, national health accounts Financing USD 4 2018–2021 WHO Global Health Expenditure Database $5.3m (2021)
HIV spending on governance and sustainability Financing USD 1 2019 UNAIDS Global AIDS Monitoring expenditure database $987k (2019)
HIV spending on prevention Financing USD 1 2019 UNAIDS Global AIDS Monitoring expenditure database $352 (2019)
HIV spending on prevention of vertical transmission Financing USD 1 2024 UNAIDS Global AIDS Monitoring expenditure database $2k (2024)
HIV spending on treatment, care and support Financing USD 2 2019–2024 UNAIDS Global AIDS Monitoring expenditure database $31k (2024)
International HIV expenditure (country-reported) Financing USD 1 2024 UNAIDS Global AIDS Monitoring expenditure database $33k (2024)
Private HIV and STD spending, national health accounts Financing USD 4 2018–2021 WHO Global Health Expenditure Database $427k (2021)
US HIV disbursements managed by USAID Financing USD 4 2023–2026 ForeignAssistance.gov $361k (2026)
US HIV disbursements managed by other US agencies Financing USD 22 2005–2026 ForeignAssistance.gov $0 (2026)
US HIV disbursements managed by the State Department Financing USD 1 2026 ForeignAssistance.gov $597k (2026)
USAID funding received by the national TB programme Financing USD 3 2019–2024 WHO Global Tuberculosis Programme $0 (2024)
% of ALL PLHIV who are virally suppressed Treatment cascade percent 5 2023–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 44.0% (2025)
% of PLHIV on ART (second 95, PLHIV base) Treatment cascade percent 87 2000–2025 UNAIDS AIDSinfo, UNAIDS HIV sub-national estimates viewer (Naomi), WHO Global Health Observatory 52.0% (2025)
% of PLHIV who have been diagnosed (first 95) Treatment cascade percent 46 2010–2025 UNAIDS AIDSinfo, UNAIDS HIV sub-national estimates viewer (Naomi), WHO Global Health Observatory 69.0% (2025)
% of estimated HIV-positive incident TB cases on TB treatment and ART Treatment cascade percent 19 2003–2024 UNAIDS AIDSinfo 65.9% (2024)
% of people currently enrolled in HIV treatment started on TB preventive therapy Treatment cascade percent 2 2023–2024 UNAIDS AIDSinfo 21.7% (2024)
% of people newly enrolled in HIV treatment diagnosed with TB disease Treatment cascade percent 2 2019–2024 UNAIDS AIDSinfo 11.7% (2024)
% of people on ART who are virally suppressed (third 95) Treatment cascade percent 3 2023–2025 WHO Global Health Observatory 84.0% (2025)
% of returned HIV test results that were positive Treatment cascade percent 22 2018–2024 UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 2.3% (2024)
HIV tests performed at a health facility Treatment cascade count 4 2018–2024 WHO HIV testing services dashboard 150,155 (2024)
HIV tests performed through community outreach Treatment cascade count 4 2018–2024 WHO HIV testing services dashboard 5,786 (2024)
HIV tests performed with the result returned to the person Treatment cascade count 29 2018–2024 Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 155,941 (2024)
HIV-exposed infants tested within two months of birth Treatment cascade percent 9 2014–2024 UNAIDS AIDSinfo 40.0% (2024)
HIV-positive TB patients started or continued on ART Treatment cascade count 19 2015–2025 Global Fund Data Service, WHO Global Tuberculosis Programme 264 (2025)
Key-population people tested for HIV (count over the period) Treatment cascade count 13 2018–2025 Global Fund Data Service By population group, sex or age only, to 2025
Number of people on ART (PEPFAR MER TX_CURR) Treatment cascade count 96 2000–2025 Global Fund Data Service, UNAIDS AIDSinfo, UNAIDS HIV sub-national estimates viewer (Naomi), WHO Global Health Observatory, WHO Global Tuberculosis Programme 12,311 (2025)
PMTCT ART coverage among pregnant women with HIV Treatment cascade percent 31 2010–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 85.0% (2025)
People living with HIV in care screened for TB Treatment cascade count 7 2017–2025 Global Fund Data Service 2,568 (2025)
People living with HIV on ART who started TB preventive therapy Treatment cascade count 3 2023–2025 Global Fund Data Service 715 (2025)
People newly enrolled on ART during the year Treatment cascade count 7 2019–2025 Global Fund Data Service, WHO Global Tuberculosis Programme 2,608 (2025)
People tested for HIV in the last 12 months who received the result (household survey) Treatment cascade percent 36 2013–2019 Demographic and Health Surveys By population group, sex or age only, to 2019
Pregnant women tested for HIV in antenatal care Treatment cascade percent 9 2015–2024 UNAIDS AIDSinfo 91.0% (2024)
Pregnant women with HIV who received ARVs for PMTCT Treatment cascade count 40 2010–2025 Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory 645 (2025)
TB patients recorded as HIV-positive Treatment cascade count 10 2015–2024 WHO Global Tuberculosis Programme 326 (2024)
TB patients with an HIV test result recorded Treatment cascade count 15 2015–2025 Global Fund Data Service, WHO Global Tuberculosis Programme 2,459 (2025)
AIDS-related deaths Epidemic estimates count 681 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 890 (2025)
Deaths from TB among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 130 (2024)
HIV prevalence among a key population Epidemic estimates percent 3 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
HIV prevalence, ages 15-49 Epidemic estimates percent 95 2000–2025 Demographic and Health Surveys, UNAIDS AIDSinfo, UNAIDS HIV sub-national estimates viewer (Naomi), World Bank Open Data 1.3% (2025)
Incident TB cases among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 460 (2024)
New HIV infections Epidemic estimates count 603 2000–2025 UNAIDS AIDSinfo, UNAIDS HIV sub-national estimates viewer (Naomi), UNICEF HIV/AIDS dataset, WHO Global Health Observatory 1,100 (2025)
People living with HIV Epidemic estimates count 699 2000–2025 UNAIDS AIDSinfo, UNAIDS HIV sub-national estimates viewer (Naomi), UNICEF HIV/AIDS dataset, WHO Global Health Observatory 24,000 (2025)
Condom use at last higher-risk sex (household survey) Prevention and outreach percent 18 2013–2019 Demographic and Health Surveys By population group, sex or age only, to 2019
Key-population people reached by outreach (count over the period) Prevention and outreach count 13 2018–2025 Global Fund Data Service By population group, sex or age only, to 2025
Male condoms distributed in a year Prevention and outreach count 4 2019–2023 UNAIDS AIDSinfo 4,864,067 (2023)
People receiving PrEP Prevention and outreach count 8 2019–2025 Global Fund Data Service, UNAIDS AIDSinfo 100 (2020)
People with comprehensive correct knowledge of HIV (household survey) Prevention and outreach percent 40 2013–2019 Demographic and Health Surveys By population group, sex or age only, to 2019
Estimated pregnant women with HIV needing ARVs for PMTCT Population denominators count 31 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 760 (2025)
Estimated size of a key population Population denominators count 3 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
Total population Population denominators count 44 2000–2025 UNAIDS HIV sub-national estimates viewer (Naomi), World Bank Open Data 2,822,093 (2025)
Share of HIV-exposed infants who acquire HIV — percent 31 2010–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 18.8% (2025)

Every row shown on the Gambia page is in the panel download, with the source URL and the retrieval date of the row attached. See Data.